IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck (IAEA-HypoX)
IAEA-HypoX. A Randomized Multicenter Study of Accelerated Fractionated Radiotherapy With or Without the Hypoxic Radiosensitizer Nimorazole in the Treatment of Squamous Cell Carcinoma of the Head and Neck
Sponsor: Danish Center for Interventional Research in Radiation Oncology (CIRRO)
Terminated
Insufficient recruitment
Other terminated trials from Danish Center for Interventional Research in Radiation Oncology (CIRRO)
More terminations from Danish Center for Interventional Research in Radiation Oncology (CIRRO)
This PHASE3 trial investigates Head and Neck Carcinoma and is currently terminated or withdrawn. Danish Center for Interventional Research in Radiation Oncology (CIRRO) leads this study, which shows 6 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Danish Center for Interventional Research in Radiation Oncology (CIRRO)
- Danish Head and Neck Cancer Group
- International Atomic Energy Agency
For direct contact, visit the study record on ClinicalTrials.gov .